Veterinarians prescribing peptides face strict oversight from state boards. Administering or dispensing unapproved, research-grade, or compounded peptides carries severe risks, including board discipline, loss of licensure, and personal liability in malpractice lawsuits. Standard malpractice insurance typically denies coverage for claims arising from unapproved treatments. Don’t you think this is a hindrance that can only be challenged and changed politically in human medicine. We have been using peptides for 35 years.
Probably not just glucagon receptor vs survodutide has 11 times GCGR potency. Thoughts? GIP backbone may affect autonomic tone, receptor density/signaling bias in SA node. Some combination of GLP GIP additive effects. Obviously stronger GCGR potency does not guarantee stronger clinical HR effects. All fascinating to me.
@ManOnThePen@TODAYshow@nbc That was great, social media never really allows you to be real. You were sincere and honest hope a lot more people follow you.
INFLAM MOTION Trial (Phase 2a): This international, randomized, double-blind, placebo-controlled trial evaluates a single IA injection of liraglutide. It is designed to enroll approximately 129 patients (aged 40–80) with grade 2-4 knee OA and synovitis. LASARE Trial (Phase 1): This multicenter trial successfully evaluated the safety, tolerability, and pharmacokinetics of single ascending doses of IA liraglutide versus a placebo. Results confirmed the drug is safe, well-tolerated, and identified an optimal pharmacologically active dose.
Have put liraglutide reta tirzepatide in equine joints no side effects much longer in the joint than subq all horses have not responded to standard treatment all have responded most are sound. These incretins are not obesity drugs they anti inflammatory Immunomodulatory drugs. The GIP has osteoblastic activity.